Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Marc Semigran > Profile

Marc Semigran

Affiliations

  • Chief Development Officer at Edgewise Therapeutics Inc. (EWTX), 2024-12-27
  • Chief Medical Officer at Renovacor Inc. (RCOR), 2022-12-06
  • Director at Social Capital Suvretta Holdings Corp. Iii (DNAC), 2021-06-30
  • Chief Medical Officer at Myokardia Inc (MYOK), 2019-02-12
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
EWTX $30.08 1,729 $52,008.84 6,716 2024-12-24 Filing
EWTX $29.66 27,980 $829,906.39 8,445 2024-12-24 Filing
MYOK $60.00 3,600 $216,000.00 0 2018-09-05 Filing
MYOK $59.49 41,400 $2,463,006.06 0 2018-09-04 Filing